{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:30:09Z","timestamp":1763037009950},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00105-016-3847-6","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T09:26:23Z","timestamp":1470302783000},"page":"753-763","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pyoderma gangraenosum"],"prefix":"10.1007","volume":"67","author":[{"given":"K.","family":"Herberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"3847_CR1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archderm.1930.01440160053009","volume":"22","author":"LA Brunsting","year":"1930","unstructured":"Brunsting LA, Goeckerman WH, Pyoderma OLPA (1930) (ecthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syphilol 22:655\u2013680","journal-title":"Arch Dermatol Syphilol"},{"key":"3847_CR2","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2012.130","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan SM, Groves RW, Card TR, Gulliford MC (2012) Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J\u00a0Invest Dermatol 132:2166\u20132170","journal-title":"J Invest Dermatol"},{"key":"3847_CR3","first-page":"173","volume":"55","author":"FC Powell","year":"1985","unstructured":"Powell FC, Schroeter AL, Su WP et\u00a0al (1985) Pyoderma gangrenosum: a review of 86 patients. Q J Med 55:173\u2013186","journal-title":"Q J Med"},{"issue":"6","key":"3847_CR4","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1365-2133.1997.20022083.x","volume":"137","author":"P Driesch von den","year":"1997","unstructured":"von den Driesch P (1997) Pyoderma gangrenosum: A report of 44 cases with follow up. Br J Dermatol 137(6):1000\u20131005","journal-title":"Br J Dermatol"},{"key":"3847_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0029-1244057","volume":"36","author":"E K\u00fchl","year":"2010","unstructured":"K\u00fchl E, Wolter M, L\u00f6ser C, Dippel E (2010) Reaktive neutrophile Dermatosen. Aktuelle Derm 36:165\u2013170","journal-title":"Aktuelle Derm"},{"key":"3847_CR6","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/jdv.12566","volume":"28","author":"SE Momen","year":"2014","unstructured":"Momen SE, Jorizzo J, Al-Niaimi F (2014) Erythema elevatum diutinum: a review of presentation and treatment. J Eur Acad Dermatol Venereol 28:1594\u20131602","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3847_CR7","first-page":"693","volume":"7","author":"A Rasch","year":"2009","unstructured":"Rasch A, Schimmer M, Sander CA (2009) Subcorneal pustulosis with combined lack of IgG\/IgM and monoclonal gammopathy type IgA\/Kappa. J\u00a0Dtsch Dermatol Ges 7:693\u2013696","journal-title":"J Dtsch Dermatol Ges"},{"key":"3847_CR8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","volume":"107","author":"CD Villarreal-Villarreal","year":"2016","unstructured":"Villarreal-Villarreal CD, Ocampo-Candiani J, Villarreal-Martinez A (2016) Sweet syndrome: A review and update. Actas Dermosifiliogr 107:369\u2013378","journal-title":"Actas Dermosifiliogr"},{"key":"3847_CR9","first-page":"1","volume":"6","author":"L Brocq","year":"1916","unstructured":"Brocq L (1916) Nouvelle contribution a l\u2019etude de phagedenisme geometrique. Ann Dermatol Syphilitigr 6:1\u201339","journal-title":"Ann Dermatol Syphilitigr"},{"issue":"4","key":"3847_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","volume":"73","author":"SF Braswell","year":"2015","unstructured":"Braswell SF, Kostopoulos TC, Ortega-Loayza AG (2015) Pathophysiology of pyoderma gangrenosum (PG): An updated review. J Am Acad Dermatol 73(4):691\u2013698. doi:10.1016\/j.jaad.2015.06.021","journal-title":"J Am Acad Dermatol"},{"key":"3847_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12463","author":"F Jockenh\u00f6fer","year":"2015","unstructured":"Jockenh\u00f6fer F, Klode J, Kr\u00f6ger K, Roesch A, Ghazal AP, Dissemond J (2015) Patients with pyoderma gangrenosum \u2013 analyses of the German DRG data from 2012. Int Wound J. doi:10.1111\/iwj.12463","journal-title":"Int Wound J"},{"issue":"1","key":"3847_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/bjd.13670","volume":"173","author":"M Caporni","year":"2015","unstructured":"Caporni M, Antiga E, Volpi W et\u00a0al (2015) The Treg\/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum. Br J Dermatol 173(1):275\u2013278. doi:10.1111\/bjd.13670","journal-title":"Br J Dermatol"},{"key":"3847_CR13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784\u2013790","journal-title":"Cell"},{"key":"3847_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cei.12394","volume":"178","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Fanoni D, Antiga E et\u00a0al (2014) Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet\u2019s syndrome. Clin Exp Immunol 178:48\u201356","journal-title":"Clin Exp Immunol"},{"key":"3847_CR15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2133.2007.08211.x","volume":"157","author":"TN Brooklyn","year":"2007","unstructured":"Brooklyn TN, Williams AM, Dunnill MG, Probert CS (2007) T\u2011cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking. Br J Dermatol 157:960\u2013966","journal-title":"Br J Dermatol"},{"key":"3847_CR16","unstructured":"Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, Crosti C (2010) Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 162(1):100\u2013107. doi:10.1111\/j.1365-2249"},{"key":"3847_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1523-1747.1998.00311.x","volume":"111","author":"Y Adachi","year":"1998","unstructured":"Adachi Y, Kindzelskii AL, Cookingham G et\u00a0al (1998) Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J\u00a0Invest Dermatol 111:259\u2013268","journal-title":"J Invest Dermatol"},{"key":"3847_CR18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0738-081X(83)90045-7","volume":"1","author":"JG Hickman","year":"1983","unstructured":"Hickman JG (1983) Pyoderma gangrenosum. Clin Dermatol 1:102\u2013113","journal-title":"Clin Dermatol"},{"key":"3847_CR19","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1001\/archderm.1976.01630370072023","volume":"112","author":"RN Shore","year":"1976","unstructured":"Shore RN (1976) Pyoderma gangrenosum, defective neutrophil chemotaxis and leukemia. Arch Dermatol 112:1792\u20131793","journal-title":"Arch Dermatol"},{"key":"3847_CR20","doi-asserted-by":"crossref","unstructured":"Hurwitz RM, Haseman JH (1993) The evolution of pyoderma gangrenosum. A clinicopathologic correlation. Am J Dermatopathol 15(1):28\u201333.","DOI":"10.1097\/00000372-199302000-00005"},{"key":"3847_CR21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1750-1172-8-136","volume":"8","author":"AP Ghazal","year":"2013","unstructured":"Ghazal AP, Herberger K, Schaller J et\u00a0al (2013) A multicentric analysis of associated factors and comorbidities in 259 patients in Germany. Orphanet J Rare Dis 8:136","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3847_CR22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","volume":"66","author":"M Braun-Falco","year":"2012","unstructured":"Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T (2012) Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) \u2013 a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 66(3):409\u2013415","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3847_CR23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.clindermatol.2013.11.004","volume":"32","author":"L Prat","year":"2014","unstructured":"Prat L, Bouaziz JD, Wallach D, Vignon-Pennamen MD, Bagot M (2014) Neutrophilic dermatoses as systemic diseases. Clin Dermatol 32(3):376\u2013388","journal-title":"Clin Dermatol"},{"key":"3847_CR24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","volume":"165","author":"AM Binus","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165:1244\u20131250","journal-title":"Br J Dermatol"},{"key":"3847_CR25","first-page":"287","volume":"68","author":"NM Blitz","year":"2001","unstructured":"Blitz NM, Rudikoff D (2001) Pyoderma gangrensoum. Mt Sinai J Med 68:287\u2013297","journal-title":"Mt Sinai J Med"},{"issue":"2","key":"3847_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0560.2003.00024.x","volume":"30","author":"AN Crowson","year":"2003","unstructured":"Crowson AN, Mihm MC, Magro C (2003) Pyoderma gangrenosum: a review. J\u00a0Cutan Pathol 30(2):97\u2013107","journal-title":"J Cutan Pathol"},{"key":"3847_CR27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","volume":"351","author":"J Callen","year":"1998","unstructured":"Callen J (1998) Pyoderma gangrenosum. Lancet 351:581\u2013585","journal-title":"Lancet"},{"key":"3847_CR28","doi-asserted-by":"crossref","unstructured":"Powell FC, Su WP, Perry HO (1996) Pyoderma gangrenosum: classification and management. J\u00a0Am Acad Dermatol 34(3):395\u2013409; quiz 410\u2013412. Review","DOI":"10.1016\/S0190-9622(96)90428-4"},{"issue":"7","key":"3847_CR29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1610-0387.2007.0328.x","volume":"5","author":"D Hasselmann","year":"2007","unstructured":"Hasselmann D, Bens G, Tilgen W, Reichrath J (2007) Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J\u00a0Dtsch Dermatol Ges 5(7):560\u2013564","journal-title":"J Dtsch Dermatol Ges"},{"key":"3847_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","volume":"23","author":"FT Veloso","year":"1996","unstructured":"Veloso FT, Carvalho J, Magro F (1996) Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 23:29\u201334","journal-title":"J Clin Gastroenterol"},{"key":"3847_CR31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","volume":"43","author":"WPD Su","year":"2004","unstructured":"Su WPD, Davis MDP, Weenig RH et\u00a0al (2004) PG: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 43:790\u2013800","journal-title":"Int J Dermatol"},{"key":"3847_CR32","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa013383","volume":"347","author":"RH Weenig","year":"2002","unstructured":"Weenig RH, Davis MD, Dahl PR, Su WP (2002) Skin ulcers misdiagnosed as pyoderma gangrenosum. N\u00a0Engl J Med 347:1412\u20131418","journal-title":"N Engl J Med"},{"issue":"6","key":"3847_CR33","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/art.34332","volume":"64","author":"AP Demidowich","year":"2012","unstructured":"Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML, Kastner DL, Holland SM (2012) Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum 64(6):2022\u20132027","journal-title":"Arthritis Rheum"},{"key":"3847_CR34","doi-asserted-by":"crossref","unstructured":"Su WP, Schroeter AL, Perry HO, Powell FC (1986) Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol 13(5):323\u2013330","DOI":"10.1111\/j.1600-0560.1986.tb00466.x"},{"key":"3847_CR35","doi-asserted-by":"crossref","unstructured":"Herberger K, Dissemond J, Hohaus K, Schaller J, Anastasiadou Z, Augustin M (2016) Therapie des Pyoderma gangrenosum \u2013 Retrospektive Analyse von 121 Patienten. Br J Dermatol : (im Druck)","DOI":"10.1111\/bjd.14619"},{"issue":"1","key":"3847_CR36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","volume":"79","author":"M Bennett","year":"2000","unstructured":"Bennett M, Jackson J, Jorizzo J et\u00a0al (2000) Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine 79(1):37\u201346","journal-title":"Medicine"},{"issue":"10","key":"3847_CR37","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/art.20559","volume":"50","author":"A Ehling","year":"2004","unstructured":"Ehling A, Karrer S, Klebl F et\u00a0al (2004) Therapeutic management of Pyoderma Gangrenosum. Arthritis Rheum 50(10):3076\u20133084","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3847_CR38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","volume":"53","author":"J Reichrath","year":"2005","unstructured":"Reichrath J, Bens G, Bonowitz A, Tilgen W (2005) Treatment recommendations for pyoderma gangrenosum: an evidence based review of the literature based on more than 350 patients. J\u00a0Am Acad Dermatol 53(2):273\u2013283","journal-title":"J Am Acad Dermatol"},{"key":"3847_CR39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","volume":"55","author":"TN Brooklyn","year":"2006","unstructured":"Brooklyn TN, Dunnill MGS, Shetty A et\u00a0al (2006) Infliximab for the treatment of pyoderma gangrensoum: a randomised, double blind, placebo controlled trial. Gut 55:505\u2013509","journal-title":"Gut"},{"key":"3847_CR40","doi-asserted-by":"crossref","first-page":"h2958","DOI":"10.1136\/bmj.h2958","volume":"350","author":"AD Ormerod","year":"2015","unstructured":"Ormerod AD, Thomas KS, Craig FE et\u00a0al (2015) Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ 350:h2958","journal-title":"BMJ"},{"key":"3847_CR41","first-page":"e8","volume":"5","author":"MA Fonder","year":"2006","unstructured":"Fonder MA, Cummins DL, Ehst BD et\u00a0al (2006) Adalimumab therapy for recalcitrant pyoderma gangrenosum. J\u00a0Burns Wounds 5:e8","journal-title":"J Burns Wounds"},{"key":"3847_CR42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2133.2005.06467.x","volume":"152","author":"VG Hubbard","year":"2005","unstructured":"Hubbard VG, Friedmann AC, Goldsmith P (2005) Systemic pyoderma gangrenosum responding to infliximab and adalimumab. Br J Dermatol 152:1059\u20131061","journal-title":"Br J Dermatol"},{"key":"3847_CR43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2230.2005.01972.x","volume":"31","author":"N Pastor","year":"2006","unstructured":"Pastor N, Betlloch I, Pascual JC et al (2006) Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept). Clin Exp Dermatol 31:152\u2013153","journal-title":"Clin Exp Dermatol"},{"key":"3847_CR44","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1365-2133.2007.08212.x","volume":"157","author":"RG Pomerantz","year":"2007","unstructured":"Pomerantz RG, Husni ME, Mody E, Qureshi AA (2007) Adalimumab for treatment of pyoderma gangrenosum. Br J Dermatol 157:1274\u20131275","journal-title":"Br J Dermatol"},{"key":"3847_CR45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bjps.2006.11.011","volume":"61","author":"FJ Rogge","year":"2008","unstructured":"Rogge FJ, Pacifico M, Kang N (2008) Treatment of pyoderma gangrenosum with the anti-TNF alpha drug \u2013 Etanercept. J Plast Reconstr Aes 61:431\u2013433","journal-title":"J Plast Reconstr Aes"},{"key":"3847_CR46","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.jaad.2005.10.058","volume":"54","author":"DB Roy","year":"2006","unstructured":"Roy DB, Conte ET, Cohen D (2006) The treatment of pyoderma gangrenosum using etanercept. J\u00a0Am Acad Dermatol 54:S128\u2013S134","journal-title":"J Am Acad Dermatol"},{"key":"3847_CR47","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-4632.2007.03286.x","volume":"46","author":"CA Charles","year":"2007","unstructured":"Charles CA, Leon A, Banta MR, Kirsner RS (2007) Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series. Int J Dermatol 46:1095\u20131099","journal-title":"Int J Dermatol"},{"key":"3847_CR48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000368824","volume":"6","author":"J Cafardi","year":"2014","unstructured":"Cafardi J, Sami N (2014) Intravenous immunoglobulin as salvage therapy in refractory Pyoderma Gangrenosum: report of a case and review of the literature. Case Rep Dermatol 6:239\u2013244","journal-title":"Case Rep Dermatol"},{"key":"3847_CR49","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-2133.2007.08217.x","volume":"157","author":"DL Cummins","year":"2007","unstructured":"Cummins DL, Anhalt GJ, Monahan T, Meyerle JH (2007) Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol 157:1235\u20131239","journal-title":"Br J Dermatol"},{"key":"3847_CR50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/095466301750163527","volume":"12","author":"JH Hagman","year":"2001","unstructured":"Hagman JH, Carrozzo AM, Campione E et al (2001) The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum. J\u00a0Dermatolog Treat 12:19\u201322","journal-title":"J Dermatolog Treat"},{"key":"3847_CR51","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1365-2133.2007.08433.x","volume":"158","author":"A Kreuter","year":"2008","unstructured":"Kreuter A, Reich-Schupke S, Stucker M et al (2008) Intravenous immunoglobulin for pyoderma gangrenosum. Br J Dermatol 158:856\u2013857","journal-title":"Br J Dermatol"},{"key":"3847_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12377","author":"I Cosgarea","year":"2014","unstructured":"Cosgarea I, Lovric Z, K\u00f6rber A, Dissemond J (2014) Successful treatment of refractory pyoderma gangrenosum with Ustekinumab only after excision of renal cell carcinoma. Int Wound J. doi:10.1111\/iwj.12377","journal-title":"Int Wound J"},{"key":"3847_CR53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0190-9622(00)90149-X","volume":"42","author":"D Richter-Hintz","year":"2000","unstructured":"Richter-Hintz D, Schuppe HC, Homey B et al (2000) Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol 42:304\u2013305","journal-title":"J Am Acad Dermatol"},{"key":"3847_CR54","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(05)78962-5","volume":"351","author":"HC Schuppe","year":"1998","unstructured":"Schuppe HC, Homey B, Assmann T et\u00a0al (1998) Topical tacrolimus for pyoderma gangrenosum. Lancet 351:832\u2013833","journal-title":"Lancet"},{"issue":"4","key":"3847_CR55","first-page":"317","volume":"13","author":"AP Ghazal","year":"2015","unstructured":"Ghazal AP, Dissemond J (2015) Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts. J\u00a0Dtsch Dermatol Ges 13(4):317\u2013324","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3847-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:57:14Z","timestamp":1498319834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3847-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["3847"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3847-6","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}